XML 59 R42.htm IDEA: XBRL DOCUMENT v3.22.4
EQUITY AWARDS (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Valuation Assumptions

The fair value of options granted was determined using the following weighted-average assumptions as of grant date, for the years ended December 31:

 

 

2022

 

 

2021

 

 

2020

 

Risk-free interest rate

 

 

2.90

%

 

 

0.98

%

 

 

0.79

%

Expected term (in years)

 

 

6.50

 

 

 

6.50

 

 

 

6.50

 

Expected stock price volatility

 

 

21.70

%

 

 

23.98

%

 

 

22.26

%

Dividend yield

 

 

2.47

%

 

 

2.35

%

 

 

2.56

%

Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the years ended December 31, 2022 and 2021 follows:

2022

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

502,780

 

 

$

25.77

 

 

 

5.59

 

 

$

5,936

 

Granted

 

 

102,500

 

 

 

35.58

 

 

 

 

 

 

 

Exercised

 

 

(69,580

)

 

 

22.49

 

 

 

 

 

 

 

Forfeited

 

 

(37,880

)

 

 

28.16

 

 

 

 

 

 

 

Balance, December 31, 2022

 

 

497,820

 

 

$

28.07

 

 

 

5.87

 

 

$

3,402

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

281,340

 

 

$

25.25

 

 

 

4.32

 

 

$

2,648

 

 

2021

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

506,200

 

 

$

26.81

 

 

 

5.82

 

 

$

1,805

 

Effect of 10% stock dividend

 

 

50,770

 

 

 

 

 

 

 

 

 

 

Granted

 

 

58,000

 

 

 

34.30

 

 

 

 

 

 

 

Exercised

 

 

(89,870

)

 

 

22.47

 

 

 

 

 

 

 

Forfeited

 

 

(22,320

)

 

 

26.16

 

 

 

 

 

 

 

Balance, December 31, 2021

 

 

502,780

 

 

$

25.77

 

 

 

5.59

 

 

$

5,936

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

295,696

 

 

$

24.09

 

 

 

4.40

 

 

$

3,989

 

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the years ended December 31, 2022 and 2021 follows:

2022

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

207,084

 

 

$

5.23

 

Granted

 

 

102,500

 

 

 

6.98

 

Vested

 

 

(71,944

)

 

 

(5.50

)

Forfeited

 

 

(21,160

)

 

 

(8.86

)

Balance, December 31, 2022

 

 

216,480

 

 

$

5.95

 

 

2021

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

214,680

 

 

$

4.46

 

Effect of 10% stock dividend

 

 

23,218

 

 

 

 

Granted

 

 

58,000

 

 

 

5.92

 

Vested

 

 

(76,494

)

 

 

(5.39

)

Forfeited

 

 

(12,320

)

 

 

(6.99

)

Balance, December 31, 2021

 

 

207,084

 

 

$

5.23

 

Plan Information

Information related to stock options in the Plan is as follows for the years ended:

 

 

2022

 

 

2021

 

 

2020

 

Intrinsic value of options exercised

 

$

846

 

 

$

1,273

 

 

$

158

 

Cash received from options exercised

 

 

1,565

 

 

 

2,019

 

 

 

638

 

Weighted average fair value of options granted

 

 

6.98

 

 

 

5.92

 

 

 

4.46

 

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the years ended December 31, 2022 and 2021 follows:

2022

 

Number of
Shares

 

 

Weighted-Average
 Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

30,190

 

 

$

27.52

 

Vested

 

 

(11,260

)

 

 

(27.52

)

Balance, December 31, 2022

 

 

18,930

 

 

$

27.51

 

 

2021

 

Number of
Shares

 

 

Weighted-Average
Grant
 Date Fair Value

 

Outstanding at beginning of year

 

 

35,300

 

 

$

29.72

 

Effect of 10% stock dividend

 

 

3,530

 

 

 

 

Granted

 

 

3,500

 

 

 

33.09

 

Vested

 

 

(12,140

)

 

 

(27.05

)

Balance, December 31, 2021

 

 

30,190

 

 

$

27.52